Sr. Principal - Clinical Data Strategist at Eli Lilly and Company

Indianapolis, Indiana, United States

Eli Lilly and Company Logo
Not SpecifiedCompensation
Expert & Leadership (9+ years)Experience Level
Full TimeJob Type
UnknownVisa
Pharmaceuticals, HealthcareIndustries

Requirements

  • Master’s degree with minimum 3 years of experience in data management (or Bachelor’s degree with 7 or more years of experience)
  • Legally authorized to be employed in the United States (no sponsorship anticipated)
  • Advanced degree (e.g., MSc, PhD) in a scientific or health care field (preferred)
  • Experience in clinical drug development with expertise in clinical data management, leading asset level clinical data strategies, defining clinical data flows, determining data modalities and/or defining requirements for data integration, mapping and normalization (preferred)
  • Demonstrated ability to effectively partner/influence to deliver results (preferred)
  • Demonstrated ability to understand and apply clinical data management skills, including data flow, data structures (preferred)

Responsibilities

  • Partner with internal and external teams to provide proactive strategic, scientific and technical input for clinical data planning and execution that enable efficient delivery of data
  • Drive project decisions related to clinical data execution options, including integrated functional sourcing, technology, automation, analytics and data collection modality
  • Ensure strong linkages exist between clinical design, execution, analytics, delivery and submission
  • Ensure data from different sources are consistent and easily consumable
  • Map collected data into predictable source/raw data
  • Collaborate with Clinical Data Associate and other Data and Analytics staff on data collection design
  • Understand inconsistencies in data and provide feedback to standards team
  • Support submission, inspection and regulatory response activities
  • Contribute to an agile organization that continuously meets the needs of a changing portfolio
  • Coach up staff who demonstrate expertise in drug development, therapeutic area science, project management and all aspects of clinical data sciences and solutions
  • Demonstrate and encourage judgment-based scientific decision making, and provide leadership in clinical data strategy, standardization, integration, analytics, automation and data submission
  • Provide scientific and technical leadership, coaching, and example to the community of Data & Analytics professionals
  • Foster inclusion, innovation and promote diversity

Skills

Clinical Data Strategy
Data Analytics
Clinical Research
Drug Development
Data Automation
Analytics
Data Integration
Data Collection
Therapeutic Area Strategy

Eli Lilly and Company

Develops and delivers prescription medicines globally

About Eli Lilly and Company

Eli Lilly and Company is a global pharmaceutical company that focuses on discovering, developing, and delivering medicines to improve health. The company has a long history of scientific achievements, including the creation of insulin, the first life-saving treatment for diabetes. Lilly's operations involve extensive research and development to create new medications and enhance existing ones, ensuring they are safe and effective. Their products are primarily prescription medicines sold to healthcare providers for various medical conditions, including diabetes, cancer, and pain management. What sets Lilly apart from its competitors is its strong commitment to ethical practices and the protection of its products from counterfeiting. The company's goal is to enhance lives through innovative medical solutions while maintaining high standards of quality and ethics.

Indianapolis, IndianaHeadquarters
1876Year Founded
$1,180.1MTotal Funding
IPOCompany Stage
Biotechnology, HealthcareIndustries
10,001+Employees

Risks

Competition from Novo Nordisk's Ozempic may impact tirzepatide's market share.
Potential construction delays in Indiana could affect GLP-1 drug production timelines.
Regulatory challenges may hinder Kisunla's expansion in new Alzheimer's markets.

Differentiation

Eli Lilly's rich history includes the first life-saving insulin treatment.
Lilly's strategic partnerships enhance its position in neurodegenerative disease treatments.
FDA approval of Zepbound opens new therapeutic markets for sleep disorder treatments.

Upsides

Lilly's $9 billion complex in Indiana boosts GLP-1 drug production capacity.
Kisunla's approval in China expands Lilly's Alzheimer's treatment market in Asia.
Collaboration with EVA Pharma enhances Lilly's reputation as socially responsible.

Land your dream remote job 3x faster with AI